Adding to a Couple of Troubled Positions as July Comes to a Close
Here’s our trading plan for Friday and the upcoming earnings calendar for portfolio names.
Selling 5 Small-Cap Names for a LIFO Profit
We looked to take advantage of some pre-earnings weakness and now we’re ready to profit.
5 Stocks We Want to Buy on Weakness Ahead of Earnings
Here’s our shopping list for Friday as well as the latest portfolio news.
Our Small-Cap Defense Name Surges After $70 Million Update
Plus, SoFi is set to release some important earnings data.
Buying More of This Small-Cap Name as Shares Fall Under Pressure
We’re also looking to take some profit after a $6.9 million update boosted another name.
Why I’m Not Chasing AMC’s Odyssey
Here’s the latest on our Ocular Therapeutix trading strategy, a planned purchase for today and some additional portfolio news.
Our Ocular Call Is Set to Expire as Market Struggles
We’re a bit handcuffed when it comes to making moves in our small-cap portfolio.
After a Tough Run for the $10K Portfolio, Time to Get Back in the Win Column
From up 32% to slightly underwater, here’s what recently went awry — and what’s next.
Two Charts, Three Buys and a Fourth Attempt
Planet Labs and Evolv both sit at critical technical areas. Here’s my trading plan.
Adding to 2 Names as We Hope Third Time’s a Charm on a Sale
A third attempt to trim Rackspace is on deck while we make a couple of buys and prepare for a Friday option expiration.